Anna Vorobyeva

Anna Vorobyeva, Ph.D., currently serves as the Head of New Product Planning and Senior Director of Corporate Strategy at Edgewise Therapeutics. Prior to this, Anna worked as an Associate at Goldman Sachs and as a Biotechnology Equity Research Associate at ROTH Capital Partners. Anna has a Ph.D. in Cellular and Molecular Biology from Drexel University and has held various research and teaching roles in the field of biology, neurogenetics, and technology commercialization. Anna's experience also includes work as a Licensing Agent Intern at Drexel University's Office of Technology Commercialization and as a Research Assistant at Johnson&Johnson in the Skin Pharmacology Group.